Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors
Clinical trial NCT04060290 · COMPLETED
Trial details
- NCT number
- NCT04060290
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-12
- Primary completion
- 2024-02-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.